Loading...

Table of Content

    25 April 2021, Volume 16 Issue 02 Previous Issue    Next Issue
    For Selected: Toggle Thumbnails
    Original article
    The impact of comorbidity of stroke and obstructive sleep-hypopnea apnea on sleep, cognition and nerve function
    XU Lei, XU Yiming, SHEN Honghua, ZHANG Yin, REN Lei
    2021, 16 (02):  97-102.  DOI: 10.16138/j.1673-6087.2021.02.007
    Abstract ( 169 )   HTML ( 6 )   PDF (650KB) ( 54 )  

    Objective To analyze the comorbidity of obstructive sleep apnea hypopnea syndrome (OSAHS) and stroke on neurological function, sleep, and cognition. Methods The cross-sectional study enrolled 396 patients from January 2015 through December 2017, including 98 with stroke only, 228 patients also complicated with OSAHS, presenting snoring and treated by the sleep center of the hospital, and 70 OSAHS patients. All groups had matched age, gender and education level, and all patients were tested by polysomnography(PSG) to obtain laboratory-based polysomnographic variables, including apnea hypopnea index(AHI), oxygen desaturation index and microarousal index, etc. The severity of stroke was assessed by National Institutes of Health Stroke Scale (NIHSS), motor function was determined with Fugl-Meyer assessment (FMA), cognitive function was evaluated based on mini-mental state examination (MMSE), and stroke-related disability was calculated with Barthel index(BI). Results The MMSE, body mass index (BMI) and status of underlying disease were significantly among groups (P<0.05). The patients with OSAHS had higher cognition and BMI (P<0.001), while higher prevalence of underlying diseases, such as hypertension, type 2 diabetes mellitus, coronary heart disease and atrial fibrillation was observed in patients with stroke patients and OSAHS (P<0.05). Comorbidity of OSAHS increased the risk of recurrence of stroke (P<0.001), however, did not affect the type, location and progression of stroke(P>0.05). The AHI and MMSE were negatively correlated (r=-0.300, P<0.001), and the severity of OSAHS was positively correlated with the changes of FMA, NIHSS, MMSE, BI and sleep parameters in patients with the comorbidity(P<0.05). Conclusions The comorbidity of OSAHS and stoke has significantly compromised cognition, neurological impairment, motor function and daily activity of patient, and predispose higher risk of recurrent stroke.

    Figures and Tables | References | Related Articles | Metrics
    The magnitude and clinical implication of SERPINA1 and FHIT methylation in non-small cell lung cancer based on analysis of TCGA database
    WANG Jiahui, LI Ning, SUN Xianwen, LIN Yingni, DING Yongjie, SONG Hejie, LI Qingyun
    2021, 16 (02):  103-107.  DOI: 10.16138/j.1673-6087.2021.02.008
    Abstract ( 315 )   HTML ( 6 )   PDF (515KB) ( 147 )  

    Objective To investigate the significance of serine protease inhibitor A1 (SERPINA1) and fragile histidine triad(FHIT) methylation in non-small cell lung cancer(NSCLC) patients based on analysis of TCGA database. Methods The information of SERPINA1/FHIT gene expression, methylation information and associated clinical manifestations were retrieved from TCGA database and analyzed both online and offline. The link between the magnitude of SERPINA1 and FHIT methylation and parameters, such as age, gender, histological-type, smoking history and TNM stage, was probed. Results The expression level of SERPINA1 was higher in tumor tissues other than adjacent non-tumor lung tissues in both lung adenocarcinoma (LUAD) and lung squamous-cell cancer (LUSC) (P<0.05). Hypomethylation of SERPINA1 was mostly observed in LUAD tissue of male patients or individuals with metastasis(P<0.05). The methylation of SERPINA1 and FHIT methylation was not affected by smoking history, nor was it associated with TNM stage or overall survival. Conclusions SERPINA1 and FHIT methylation might play a role in lung cancer. Hypomethylation in SERPINA1 is related with metastasis of LUAD.

    Figures and Tables | References | Related Articles | Metrics
    Burden of pneumonia-associated hospitalizations: Jiading, Shanghai, 2013—2018
    CHENG Ting, QIAN Haiming, GU Weimin, SHAO Zhenyi, TIAN Yuan, ZHANG Juanping, CHENG Qijian
    2021, 16 (02):  108-115.  DOI: 10.16138/j.1673-6087.2021.02.009
    Abstract ( 144 )   HTML ( 2 )   PDF (756KB) ( 38 )  

    Objective To acquire data regarding to the incidence and prevalence of pneumonia requiring hospitalization in Shanghai, China. Methods All patients with diagnosis recorded using International Classification of Diseases Tenth Revision (ICD-10), discharged or died from any medical institutions in Jiading District of Shanghai, from 2013 to 2018, were screened. The clinical data of patients with pneumonia and main diagnosis coded in J13-J18 were collected. The number of residents in Jiading District from 2013 to 2018 was taken from the Shanghai Statistical Yearbook; the gender and age composition ratio were uniformly taken from the 1% population sampling survey in Shanghai in 2015. Results From 2013 to 2018, there were 598 598 discharged patients in Jiading District, including 25 204 patients(4.21%) with pneumonia as the main diagnosis. The average length of hospitalization was 11.5 d, and the average hospitalization cost was 6 921 yuan. The annual incidence of pneumonia requiring hospitalization was 2.67 per 1 000 population. The highest prevalence was found in the infants lower than 1 year old, 38.09 per 1 000 population, and the incidence declined dramatically in elder population, with the lowest annual incidence, 0.23 per 1 000 population, observed in age group of 25-29 years. The incidence increased in elder population and age group of over 95 years old had an annual incidence of 19.81 per 1 000 population. The incidence in men under 5 and above 70 years old was significantly higher than that in women of the same age group. The incidence rate of pneumonia in man with 5-9 years old, 20-34 years old and 50-59 years old was significantly lower than that in women of the same age group. The average inhospital mortality of pneumonia was 1.75%. The mortality of children, adolescents, young and middle-aged patients was very low. The mortality of elderly patients was higher and increased with age. The mortality rate of 90-94 years old group was 11.28%. Conclusions The annual incidence rate of pneumonia in Jiading District is 2.67 per 1 000 population. The incidence and mortality in the elderly are very high. The prevention and treatment of pneumonia in elderly is an important issue in the aging of population.

    Figures and Tables | References | Related Articles | Metrics
    Reliability and validity of the ultra-brief screening scale for depression and anxiety in outpatients clinics of community healthcare centers
    QIAN Jie, JIANG Minmin, CHEN Chen, CHEN Yujiao, YU Dehua, LI Chunbo
    2021, 16 (02):  116-120.  DOI: 10.16138/j.1673-6087.2021.02.010
    Abstract ( 406 )   HTML ( 12 )   PDF (516KB) ( 266 )  

    Objective To preliminary evaluate the reliability and validity of the ultra-brief screening scale for depression and anxiety [patient health questionnaire 4 (PHQ-4)] in outpatients clinics of community healthcare centers. Methods Totally 313 patients were randomly selected from two community healthcare centers in Shanghai. The patients were asked to complete the PHQ-4 following the prescribed instruction with assistance of a psychiatrist and two physicians, and then were evaluated according Hamilton depression scale(HAMD) and the Hamilton anxiety scale(HAMA) followed by a mini international neuropsychiatric interview(MINI). Out of subjects screened, 50 patients were randomly selected to retest the PHQ-4. The reliability coefficients, retest reliability and criterion validity sensitivity and specificity were calculated. The receiver operating characteristic(ROC) analysis was performed to determine the best cut-off value, and the sensitivity and specificity accordingly. Results The Cronbach’α coefficient of PHQ-4 was 0.833, the Spearman-Brown coefficient of the split-half reliability was 0.835. For the test-retest reliability, the intraclass correlation coefficient (ICC) was 0.969. The correlation coefficients of generalized anxiety disorder 7(GAD-7) with HAMD and HAMA were 0.391 and 0.407 respectively, both statistically significant (P<0.01). ROC analysis showed that the area under curve(AUC) was 0.919, and the best cut-off value was 3, the sensitivity and specificity of PHQ-4 were 87.1% and 82.6% respectively. Conclusions The Chinese version of the PHQ-4 maintains high reliability and validity in outpatient clinics of community healthcare centers, and is suitable for the screening of depression and anxiety.

    Figures and Tables | References | Related Articles | Metrics
    The serum level of microRNA-486-3p and its effects on proliferation and apoptosis of pancreatic cancer cells
    LI Xiaoli, LI Weiguang, QIAN Aihua, CAO Guoliang
    2021, 16 (02):  121-125.  DOI: 10.16138/j.1673-6087.2021.02.011
    Abstract ( 195 )   HTML ( 2 )   PDF (541KB) ( 90 )  

    Objective To investigate the serum level of microRNA-486-3p (miR-486-3p) and its effects on proliferation and apoptosis of pancreatic cancer cells. Methods Twenty-one patients with pancreatic cancer and twenty healthy controls were enrolled. Real-time polymerase chain reaction(PCR) was used to detect the serum miR-486-3p. The effects of miR-486-3p on pancreatic cancer cells proliferation and apoptosis were respectively examined by cell counting kit 8(CCK8) assay and flow cytometry assay. Results Compared with healthy controls,serum level of miR-486-3p was significantly up-regulated in patients with pancreatic cancer (50.73±0.82 vs 34.80±0.74, P<0.05); The proliferation of pancreatic cancer cells were significantly up-regulated (SW1990: 2.77±0.07 vs 2.05±0.06, P<0.05; PANC-1: 2.81±0.04 vs1.89±0.04, P<0.05) and the apoptosis rates were suppressed by forced expression of miR-486-3p(24.1%±1.14% vs 45.9%±1.11%, P<0.05; 21.9%±0.25% vs 42.3%±1.62%, P<0.05), while inhibition of miR-486-3p significantly down-regulated the proliferation of pancreatic cancer cells(SW1990: 1.71±0.03 vs 2.07±0.05, P<0.05; PANC-1: 1.61±0.03 vs 2.20±0.07, P<0.05). Conclusions The serum miR-486-3p were significantly up-regulated in patients with pancreatic cancer; MiR-486-3p may function as a tumor-promoter by promoting cell proliferation and suppressing apoptosis in pancreatic cancer cells.

    Figures and Tables | References | Related Articles | Metrics